Therapeutic time window important factor for cord blood cell transplantation after stoke

October 1, 2012

A research team from Germany has found that optimal benefit and functional improvement for ischemic stroke results when human umbilical cord blood mononuclear cells (hUCB MNCs) are transplanted into rat stroke models within 72 hours of the stroke. Their study is published in the current issue of Cell Transplantation (21:6), now freely available on-line.

" is one of the most frequent causes of death and the most common reason for permanent disabilities in adults in industrialized nations," said Dr. Johannes Boltze, study corresponding-author from the University of Leipzig. "Despite recent research, treatment opportunities are limited and the only approved therapy to date must be administered within a narrow four and a half hour ."

According to the authors there is a "strong demand for alternative strategies," and among those most recently studied is using neonatal or . Their study investigates the time-dependent efficacy of hUCB MNCs following experimental brain ischemia in rats. The emphasis of their study was exploring factors that impact on Cell Transplantation to derive the best outcomes, such as determining an appropriate transplantation time point, or window of opportunity.

The researchers transplanted hUCB MNCs into test animals at various time intervals following stroke, at four hours, 24 hours, 72 hours, 120 hours and at 14 days.

"Our results demonstrated that transplantation within a 72 hour time window resulted in an early improvement in functional recovery," said Dr. Boltze.

"The failure to induce sustained functional recovery, lesion reduction, and limitation of glial scaring in animals treated at 120 hours indicates the 72 hour time window as efficient for cell application."

The authors noted that administration of hUCB MNCs within the 72 hour window resulted not only in but also a reduction in and in diminished glial scaring demonstrating the importance of this factor on the impact of umbilical cord blood Cell Transplantation. Later transplantation, at 14 days, showed no benefit.

"Our study shows that hUCB MNCs are a promising tool for acute stroke treatment, but require a comparatively early intervention in the subacute phase of ," concluded the authors.

"This research adds to a growing body of evidence supporting specific early time periods for repair of the brain, spinal cord, heart and other organs following acute injury and is very important in the development of regenerative therapies" said Dr. Paul R. Sanberg, Distinguished Professor of Neurosurgery and Brain Repair at the University of South Florida.

Explore further: Mannitol boosts effectiveness of potential cord blood treatment for cerebral palsy in lab animals

More information: Boltze, J.; Schmidt, U. R.; Reich, D. M.; Kranz, A.; Reymann, K. G.; Strassburger, M.; Lobsien, D.; Wagner, D.-C.; Förschler, A.; Schäbitz, W.-R. Determination of the Therapeutic Time Window for Human Umbilical Cord Blood Mononuclear Cell Transplantation Following Experimental Stroke in Rats. Cell Transplant. 21(6):1199-1211; 2012. http://www.ingentaconnect.com/content/cog/ct/

Related Stories

Recommended for you

New method creates endless supply of kidney precursor cells

August 25, 2016

Salk Institute scientists have discovered the holy grail of endless youthfulness—at least when it comes to one type of human kidney precursor cell. Previous attempts to maintain cultures of the so-called nephron progenitor ...

New avenue for understanding cause of common diseases

August 25, 2016

A ground-breaking Auckland study could lead to discoveries about many common diseases such as diabetes, cancer and dementia. The new finding could also illuminate the broader role of the enigmatic mitochondria in human development.

Strict diet combats rare progeria aging disorders

August 25, 2016

Mice with a severe aging disease live three times longer if they eat thirty percent less. Moreover, they age much healthier than mice that eat as much as they want. These are findings of a joint study being published today ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.